Document Detail

Blood Lead in End-Stage Renal Disease (ESRD) Patients who were on Maintainence Haemodialysis.
MedLine Citation:
PMID:  23373016     Owner:  NLM     Status:  PubMed-not-MEDLINE    
BACKGROUND: In India, there is rising burden of chronic diseases like hypertension and diabetes. It has been estimated that 25-40% of these patients are likely to develop CKD, with a significant percentage requiring renal replacement therapy. Haemodialysis is the most common method which is used to treat advanced and permanent kidney failure. The derangements in the metabolism of several toxic and trace elements such as antimony, arsenic, cadmium, molybdenum, nickel, and selenium have been reported for several decades in patients with chronically reduced renal function. Overall, the available literature suggests that the blood levels of some elements such as cadmium, chromium, fluorine, iodine, lead and vanadium are high in ESRD.
AIM AND OBJECTIVES: Our aim was to study the levels of blood lead in the End-Stage Renal Disease (ESRD) patients who were on Maintenance Haemodialysis (MHD), and to study whether there was any relationship between the blood lead concentration and the duration of MHD.
METHODS: The blood lead level was determined in 50 healthy subjects with normal renal function and in 50 patients with ESRD who were on MHD. None of them had a history of smoking or any industrial exposure.
RESULTS: The results of this study revealed that the blood lead level was higher in the ESRD patients who were on MHD than in the healthy adults. The blood lead concentration was found to increase with the duration of the MHD.
CONCLUSION: The mild increase in the blood lead level with an increase in the duration of MHD in the study population, may be viewed in the wider context that the prolonged exposure to lead, even at low levels may result in CKD by causing interstitial nephritis, hypertension, hyperuricaemia, an increased incidence of hypertension, cerebrovascular disease and cardiovascular disease or the progression of an already existing CKD.
Subha Palaneeswari M; P M Abraham Sam Rajan; Silambanan Santhi; Jothimalar
Related Documents :
17726816 - The use of levonorgestrel - iud in the treatment of uterine myoma in thai women.
11179066 - Role of leukocytes in uterine hypoperfusion and fetal growth retardation induced by isc...
12475576 - Misoprostol and dinoprostone therapy for labor induction: a doppler comparison of uteri...
8981146 - Ultrasound derived indices of follicular blood flow before hcg administration and the p...
300556 - Effects of amyl nitrite on phasic aortocoronary bypass graft blood velocity in man.
10277636 - Distinguishing characteristics of blood donor segments defined in terms of donation fre...
Publication Detail:
Type:  Journal Article     Date:  2012-10-14
Journal Detail:
Title:  Journal of clinical and diagnostic research : JCDR     Volume:  6     ISSN:  2249-782X     ISO Abbreviation:  J Clin Diagn Res     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2013-02-01     Completed Date:  2013-02-04     Revised Date:  2013-05-30    
Medline Journal Info:
Nlm Unique ID:  101488993     Medline TA:  J Clin Diagn Res     Country:  India    
Other Details:
Languages:  eng     Pagination:  1633-5     Citation Subset:  -    
Assistant Professor, Department of Biochemistry, Sree Balaji Medical College and Hospital , Chennai, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The oxidative stress in cataract patients.
Next Document:  The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular m...